Rosenqvist, Mari
Bronton, Kevin http://orcid.org/0000-0001-5876-2655
Hartmann, Oliver
Bergmann, Andreas
Struck, Joachim
Melander, Olle
Funding for this research was provided by:
Hjärt-Lungfonden (20180278)
Vetenskapsrådet (2018-02760)
Article History
Received: 19 August 2019
Accepted: 24 October 2019
First Online: 28 November 2019
Ethics approval and consent to participate
: The study was approved by the Regional Ethical Review Board in Lund, Lund University, Sweden (2013/635) and conducted in accordance with the Helsinki Declaration. Both written and oral informed consent was obtained from all patients or their next of kin after they had the opportunity to read and review a written description of the study design and purpose.
: Not applicable.
: A.B. has shares in and is CEO of Sphingotec GmbH, the company providing and having the patent rights on the penKid assay and its use for the prediction/diagnosis of AKI. J.S. and OH are employees of Sphingotec GmbH. The other authors report no conflicts of interest.